Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Pingping,Lin

第一单位： Clinical Trials Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

作者： Pingping,Lin ^[1] ; Chengqian,Li ^[2] ; Yanping,Liu ^[1] ; Feifei,Sun ^[1] ; Tsung-Han,Hsieh ^[3] ; Lin Zhang ^[3] ; Yaping,Ma ^[1] ; Xiaomeng,Gao ^[1] ; Qing,Yu ^[2] ; Yu,Cao ^[1]

作者单位： Clinical Trials Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. ^[1] Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. ^[2] Shanghai Benemae Pharmaceutical Corporation, Shanghai, China. ^[3]

关键词 beinaglutide glucagon-like peptide 1 obesity overweight pharmacokinetics

DOI 10.3389/fphar.2024.1433587

PMID 39239660

发布时间 2024-09-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2024年15卷

1433587页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除